Scarica l'app Stockscreener
14.85
5.73%
0.805
Dopo l'orario di chiusura:
14.83
-0.02
-0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ATRA Giù?
Forum
Previsione
Precedente Chiudi:
$14.04
Aprire:
$13.99
Volume 24 ore:
51,373
Relative Volume:
0.99
Capitalizzazione di mercato:
$104.29M
Reddito:
$100.44M
Utile/perdita netta:
$-133.16M
Rapporto P/E:
-0.5765
EPS:
-25.76
Flusso di cassa netto:
$-94.85M
1 W Prestazione:
+2.48%
1M Prestazione:
+3.63%
6M Prestazione:
+85.86%
1 anno Prestazione:
+66.67%
Intervallo 1D:
$13.99
$14.89
Intervallo di 1 settimana:
$13.30
$15.74
Portata 52W:
$5.005
$18.70
Atara Biotherapeutics Inc Stock (ATRA) Company Profile
Nome
Atara Biotherapeutics Inc
Settore
Industria
Telefono
805-623-4211
Indirizzo
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA
Confronta ATRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATRA
Atara Biotherapeutics Inc
|
14.85 | 98.64M | 100.44M | -133.16M | -94.85M | -25.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atara Biotherapeutics Inc Stock (ATRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-11-09 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-11-09 | Downgrade | Mizuho | Buy → Neutral |
| 2022-07-20 | Downgrade | Citigroup | Neutral → Sell |
| 2022-07-13 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-13 | Downgrade | Stifel | Buy → Hold |
| 2022-05-10 | Downgrade | Citigroup | Buy → Neutral |
| 2021-05-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-12-09 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-11-10 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-30 | Iniziato | Evercore ISI | Outperform |
| 2020-06-15 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-23 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-11-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-09-27 | Downgrade | Goldman | Neutral → Sell |
| 2019-09-16 | Downgrade | Jefferies | Buy → Hold |
| 2019-06-04 | Aggiornamento | Citigroup | Sell → Neutral |
| 2019-05-30 | Iniziato | ROTH Capital | Buy |
| 2019-05-23 | Iniziato | Stifel | Buy |
| 2019-01-23 | Iniziato | Mizuho | Buy |
| 2018-04-10 | Iniziato | JP Morgan | Overweight |
| 2018-03-16 | Iniziato | Guggenheim | Neutral |
| 2018-03-05 | Reiterato | Jefferies | Buy |
| 2018-02-28 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-02-15 | Downgrade | Citigroup | Neutral → Sell |
| 2018-01-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2017-10-06 | Ripresa | Goldman | Neutral |
Mostra tutto
Atara Biotherapeutics Inc Borsa (ATRA) Ultime notizie
Is Atara Biotherapeutics Inc. (AT20) stock nearing a technical breakout2025 Earnings Impact & Fast Moving Stock Watchlists - newser.com
Live market analysis of Atara Biotherapeutics Inc.Weekly Trade Summary & Detailed Earnings Play Strategies - newser.com
Will Atara Biotherapeutics Inc. (AT20) stock beat value stocksJuly 2025 Big Picture & Low Drawdown Trading Techniques - newser.com
Will Atara Biotherapeutics Inc. (AT20) stock sustain uptrend momentumMarket Volume Report & Capital Efficient Trade Techniques - newser.com
Will Atara Biotherapeutics Inc. stock maintain growth storyQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com
How robust is Atara Biotherapeutics Inc. (AT20) stock financial positionJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Custom strategy builders for tracking Atara Biotherapeutics Inc.Trade Analysis Report & Fast Gain Stock Trading Tips - newser.com
How hedge fund analytics apply to Atara Biotherapeutics Inc. stockNew Guidance & Verified Momentum Stock Watchlist - newser.com
Is Atara Biotherapeutics Inc. stock supported by strong fundamentals2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
How Atara Biotherapeutics Inc. (AT20) stock performs during market turbulenceJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
How to recover losses in Atara Biotherapeutics Inc. stockLayoff News & Safe Entry Zone Tips - newser.com
Will Atara Biotherapeutics Inc. stock attract ESG investorsJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
Is Atara Biotherapeutics Inc. forming a bottoming baseMarket Trend Review & Reliable Volume Spike Alerts - newser.com
Institutional scanner results for Atara Biotherapeutics Inc.July 2025 WrapUp & Real-Time Market Sentiment Reports - newser.com
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
5 Under-the-Radar Biotech Stocks That Could Soar in 2026 - Barchart.com
Will a bounce in Atara Biotherapeutics Inc. offer an exit2025 Trading Recap & Intraday High Probability Alerts - newser.com
Immatics (NASDAQ: IMTX) names Amie Krause CPO to lead HR amid commercial-stage transition - Stock Titan
Atara Biotherapeutics Inc Azioni (ATRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):